kaal:position:2026-07-31-4862

Abstract 17419: Differential Roles of Rap1 Isoforms in Regulation of Vascular Permeability and Endothelial Cell Barrier should be assessed against Kaal's source-bound claim that Put option based discount models for lack of marketability have been widely used, but they can be inaccurate because real investors do not possess perfect market timing ability. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

prospective put model and related put option DLOM models
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Abstract 17419: Differential Roles of Rap1 Isoforms in Regulation of Vascular Permeability and Endothelial Cell Barrier

Scholarly basis

kaal:claim:4033886-023
Wulf A. Kaal, Samuel Evans, Hayley Howe, Digital Asset Valuation (2022). SSRN: https://ssrn.com/abstract=4033886
Source PDF sha256: 52ba05b1292b1be4bfaf1ee5cf56b14fea9c196d870603e794d7ee316df129bd

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.2141
Mapping ambiguous: true

Topics

economicsdefi

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0020 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: dc163cd0a9df077b72de63e11f0e4bbaff828eb8ed9aa76e070c527f8880a43b
curl -s https://wulfkaal.github.io/positions/2026-07-31-4862.md | sha256sum